Introduction of HIV drug-resistance testing in clinical practice

被引：59

作者：

Rodríguez-Rosado, R ^{[1
]}

Briones, C ^{[1
]}

Soriano, V ^{[1
]}

机构：

[1] Inst Salud Carlos III, Hosp Carlos III, Infect Dis Serv, Madrid, Spain

来源：

AIDS | 1999年 / 13卷 / 09期

关键词：

diagnosis; drug resistance; highly active antiretroviral therapy; viral load;

D O I：

10.1097/00002030-199906180-00001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1007 / 1014

页数：8

共 47 条

[1] Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients [J].

Birk, M ;

Sönnerborg, A .

AIDS, 1998, 12 (18) :2369-2375

[2]

BLOOR S, 1998, ANTIVIR THER S, V3, P13

[3] Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86

[4] In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor [J].

Carrillo, A ;

Stewart, KD ;

Sham, HL ;

Norbeck, DW ;

Kohlbrenner, WE ;

Leonard, JM ;

Kempf, DJ ;

Molla, A .

JOURNAL OF VIROLOGY, 1998, 72 (09) :7532-7541

[5]

CLEVENBERG P, 1998, 4 INT C DRUG THER HI

[6] COMPARISON OF THE SENSITIVITIES OF PRIMARY ISOLATES OF HIV TYPE-2 AND HIV TYPE-1 TO ANTIVIRAL DRUGS AND DRUG-COMBINATIONS [J].

COX, SW ;

APERIA, K ;

ALBERT, J ;

WAHREN, B .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) :1725-1729

[7]

DEALANEY S, 1998, 12 WORLD AIDS C GEN

[8] Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy [J].

DeAntoni, A ;

Foli, A ;

Lisziewicz, J ;

Lori, F .

JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04) :899-903

[9]

DEEKS S, 1998, ANTIVIRAL THERAPY S1, V3, P36

[10]

DEJONG J, 1998, ANTIVIR THER S, V3, P15

← 1 2 3 4 5 →